Defective Drugs
Dangerous Drugs Can Prolong Illness and Worsen Conditions
Millions of Americans are injured or killed every year by dangerous prescription drugs that cause unexpected side effects and complications. Pharmaceuticals are widely used to treat a wide range of diseases and conditions, from high-blood pressure and diabetes to pain management and heart disease. However, in some cases, prescription drugs are dangerous and actually worsen a patient’s physical condition, prolonging illness and suffering.
The U.S. Food and Drug Administration (FDA) is the agency charged with testing new drugs before the products are approved for use in patients. The agency also sets standards for the pharmaceutical industry, including the packaging of drugs and warnings on the packaging. Despite strict testing and research of pharmaceuticals, dangerous drugs still make it to market, where they are taken by patients who suffer pain, injuries, and death.
WHAT DISEASES AND CONDITIONS MAY BE CAUSED BY DANGEROUS DRUGS?
Drugs that have dangerous side effects or cause life-threatening adverse reactions when taken in combination with other drugs may cause a variety of serious diseases and conditions, including:
- Birth defects
- Heart attack, heart failure, irregular heartbeat, and other cardiac problems
- Stroke
- Liver disease or liver failure
- Hypertension
- Respiratory disorders
- Death
WHAT IS A DRUG RECALL?
When the potential benefits of a drug are outweighed by the potential risk of injuries to people taking the drug, the FDA may step in and order the drug removed from the market. Drugs are commonly recalled for manufacturing defects, contamination, and when research studies detect an unreasonably high risk of harm to people taking the drugs. The goal of a product recall is to remove potentially harmful drugs from the market before they can reach patients, causing injuries.
In some cases, the FDA may allow a potentially dangerous drug to remain in circulation, but order the manufacturer to add warnings to the drug’s packaging, change the recommended dosage, or make other changes intended to protect users. This action, while not a recall, is also intended to protect consumers from dangerous drugs.
Recent Related Features
All Stories
Panel Says Yaz Label Should Be Re-Written
In a 21 to 5 vote, the U.S. Food and Drug Administration said that the labels on certain oral contraceptive drugs should be rewritten to reflect risks accurately. The pills in question contain the hormone drospirenone. The brand names for these products include Yaz, Yasmin, Beyaz and Sayfral. Some studies suggest that the risk is higher for venous thromboembolism (VTE) in birth control pills with drospirenone than those with another hormone called levonorgestrel, a progestin. VTE occurs when blood clots …
Breast Cancer Drug Revoked for “Life-Threatening” Risks
The government revoked the approval of breast cancer drug Avastin last week, citing dangerous side effects and a lack of evidence that it prolongs life. FDA Commissioner Margaret Hamburg said it was a “difficult decision,” referencing the patients who have been lobbying to keep the drug. But, she added that “it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit, in terms …
Acetaminophen Linked to Asthma
Acetaminophen may make asthma symptoms worse in children and adults, according to a new report published in the journal Pediatrics. The report reviewed recent studies on the medication, which is also marketed as Tylenol. The studies reviewed suggested that acetaminophen may even trigger new case of asthma. One of the studies surveys 520,000 children from 122 centers in 54 countries. In a report on that data published in The Lancet in 2008, researchers found that the risk of developing asthma …
FDA Says Bayer Birth Control Pills Could Double Blood-Clot Risk
The Food and Drug Administration is warning that birth control pills made by Bayer AG could significantly increase the risk of blood clots. A recent study released by the FDA said that women taking pills containing the hormone drospirenone are 74 percent more likely to experience clots than those on low- estrogen pillsThe issue will be further discussed in December, federal authorities said. Bayer’s pills contain drospirenone, which is similar to the natural female hormone progesterone. The study evaluated data …
Risky Pregnancy Drug Raised Cancer Odds
A synthetic estrogen called DES taken by millions of pregnant women to prevent miscarriage and other complications may have raised their daughters’ risk of cancer, new research shows. The new study suggests that the health effects of the drug may include infertility and twice the risk of breast cancer. The sons of DES users also face health risks — testicular problems and cysts — but these are less well studied and don’t seem to be as common. Even grandchildren may …
Avastin Could Harm Fertility
Roche’s cancer drug Avastin could affect fertility in some women, the Food and Drug Administration is reporting. A new warning about “ovarian failure” has been added to Avastin’s label, and doctors are being advised to educate women of child-bearing age that Avastin may stop ovaries from releasing eggs regularly. Other updated information in the drug label includes a warning about the risk of blood clots and bleeding risk. The label also warns about possible side effects that include stroke, fatal …
FDA Concerned About Yaz
The FDA is remaining concerned about a type of birth control pill that could raise the risk of blood clots more than other pills on the market. The pills known as Yaz or Yasmin, marketed by Bayer AG, contain drospirenone. Drospirenone is a type of female sex hormone called a progestin. Although all birth control pills raise the risk of blood clots, some studies have reported that the risk of blood clots for women who use birth-control pills containing drospirenone …
Johnson & Johnson Recalls Eprex Anemia Drug
Johnson & Johnson is recalling about 200,000 syringes of Eprex, an anemia drug sold wholesale and in pharmacies. Some batches of the drug may not be potent enough, health regulators are warning. The recall affects products in 17 countries, including the U.K and Canada. No adverse events have been tied to the issue, J&J says. The manufacturer assumes that the prefilled syringes have already been used, since they were delivered to the market quite a while ago. There are around …
Misunderstanding of Drug Approval Process Common
Many people believe that drugs given the go-ahead by the Food and Drug Administration are safer than they have to be to get approval, according to a study. Researchers found that in the first few years after a drug is approved, there are still questions about how well it will work. The 3,000-person web-based survey found that one quarter believed that the FDA only approves drugs without serious side effects. Another 39 percent thought that only “extremely effective” drugs were …
FDA Warns of Allergic Reactions with Merck’s Saphris
Merck & Co Inc.’s Saphris has been associated with severe allergic reactions, according to a Food and Drug Administration report. The drug’s label has been revised to include information about the newly discovered risk. Saphris, first approved in 2009, is used to treat symptoms of schizophrenia and bipolar disorder. Since then, an estimated 235,000 prescriptions have been written for about 87,000 patients in the U.S. Allergic reactions noted may include anaphylaxis, swelling, low blood pressure and swollen tongue, the FDA …
facebook
rss
twitter